RosTrace

Tag: WomensHealth

Robin Hayes

FDA Approves First At-Home HPV Test as Alternative to In-Office Pap Smear

On May 11, 2025, the U.S. Food and Drug Administration (FDA) granted approval for the country’s first at-home human papillomavirus (HPV) test designed as an optional alternative to the traditional in-office Pap smear. Manufactured by MedAware Diagnostics (a subsidiary of Hackensack Meridian Health), the test enables individuals with a cervix to collect their own vaginal sample via a soft, sponge-like swab. Following a telehealth consultation, patients mail their specimens to a central laboratory for HPV analysis. Those who receive a positive result are promptly referred for an in-office Pap smear and follow-up care, while patients testing negative can safely defer further screening for three to five years in accordance with established guidelines.

· 6 min read

Robin Hayes

Endometriosis May Double Risk of Premature Menopause, Large Global Study Finds

A new global study from the University of Queensland has found that women with endometriosis are significantly more likely to experience premature or early menopause—especially if brought on by surgery—posing long-term risks to their health. Drawing on data from nearly 280,000 women across Australia, the UK, Sweden, and Japan, the research provides the most extensive evidence to date that endometriosis can influence not only fertility but also the timing and type of menopause.

· 3 min read